Parthenon readies sale of Trinity Life Sciences

The anticipated sale process comes fresh on the heels of GHO Capital’s recent $700m-plus bet for another life sciences strategy consulting business, ClearView Healthcare Partners.

BySarah Pringle

11 August 2021•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Featured Top Stories

Parthenon readies sale of Trinity Life Sciences

Parthenon Capital

GHO Capital Partners

Houlihan Lokey

Jefferies

Related articles